The FDA has officially awarded Novavax a “fast track” designation, while Pfizer could receive emergency approval and head into distribution by the end of this month.
The FDA has officially awarded Novavax a “fast track” designation, while Pfizer could receive emergency approval and head into distribution by the end of this month.
Headlines with a Voice 